Table 1.

Univariate Logistic Regression Analysis to Determine Predictors of Response (CR/CRi) to Venetoclax with Azacitidine

Predictor	Odds Ratio (95% CI)	p Value
Age	1.04 (0.99, 1.10)	0.1521
Prior treatment (ref = no)	0.075 (0.017, 0.334)	0.0007
Antecedent hematological disorder	1.01 (0.30, 3.44)	0.9918
Treatment-related AML	0.26 (0.05, 1.32)	0.1048
Cytogenetic risk group	6.46 (1.75, 23.92)	0.0120
TP53 mutation	0.58 (0.09, 3.80)	0.9503
FLT3 ITD mutation	0.32 (0.08, 1.28)	0.9752
ASXL1 mutation	0.57 (0.15, 2.07)	0.9560
European LeukemiaNet risk group	0.11 (0.01, 0.91)	0.9556